Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 07-Jul-10 7:26 PM View:  | Gordon Eben S VP, Regulatory Affairs | SenoRx, Inc. (SENO) | 06-Jul-10 | Disposition | 15,356 | -- | -- | (100%) 15.36K to 0 | |
| 07-Jul-10 7:17 PM View: | Cousins Kevin J VP, Finance and CFO | SenoRx, Inc. (SENO) | 06-Jul-10 | Disposition | 53,582 | -- | -- | (100%) 53.58K to 0 | |
| 07-Jul-10 7:28 PM View: | Bender A Thomas Director | SenoRx, Inc. (SENO) | 06-Jul-10 | Disposition | 36,652 | -- | -- | (100%) 36.65K to 0 | |
| 07-Jul-10 7:53 PM View: | Waller Gregory D Director | SenoRx, Inc. (SENO) | 06-Jul-10 | Disposition | 652 | -- | -- | (100%) 0.65K to 0 | |
| 07-Jul-10 7:51 PM View: | Dotzler Frederick J Director | SenoRx, Inc. (SENO) | 06-Jul-10 | Disposition | 703,361 | -- | -- | (100%) 703.36K to 0 | |
| 07-Jul-10 7:14 PM View: | Buhler John T CEO, President & COO Director | SenoRx, Inc. (SENO) | 06-Jul-10 | Disposition | 7,130 | -- | -- | (100%) 7.13K to 0 | |
| 07-Jul-10 7:18 PM View: | Lubock Paul SVP & Chief Technology Officer | SenoRx, Inc. (SENO) | 06-Jul-10 | Disposition | 195,397 | -- | -- | (100%) 195.4K to 0 | |
| 07-Jul-10 7:25 PM View: | Gearhart William F VP, Global Mkting & Corp. Dev. | SenoRx, Inc. (SENO) | 06-Jul-10 | Disposition | 34,516 | -- | -- | (100%) 34.52K to 0 | |
| 07-Jul-10 7:52 PM View: | Erb John L Director | SenoRx, Inc. (SENO) | 06-Jul-10 | Disposition | 10,652 | -- | -- | (100%) 10.65K to 0 | |
| 07-Jul-10 7:47 PM View: | Blickenstaff Kim D Director | SenoRx, Inc. (SENO) | 06-Jul-10 | Disposition | 652 | -- | -- | (100%) 0.65K to 0 | |
| 07-Jul-10 7:49 PM View: | Capps Vickie L Director | SenoRx, Inc. (SENO) | 06-Jul-10 | Disposition | 15,652 | -- | -- | (100%) 15.65K to 0 | |
| 07-Jul-10 7:51 PM View: | Dotzler Frederick J Director | SenoRx, Inc. (SENO) | 06-Jul-10 | Disposition | 36,806 | -- | -- | (5%) 740.17K to 703.36K | |
| 29-Jun-10 2:06 PM View: | Wheeler Kurt 10% Owner | SenoRx, Inc. (SENO) | 28-Jun-10 | Market Sale Duplicate | 46,600 | $10.97 | $511,202.00 | (1%) 4.06M to 4.02M | < 1% |
| 29-Jun-10 2:01 PM View: | Mpm Bioventures II Qp Lp 10% Owner | SenoRx, Inc. (SENO) | 28-Jun-10 | Market Sale | 46,600 | $10.97 | $511,202.00 | (1%) 4.06M to 4.02M | < 1% |
| 29-Jun-10 2:06 PM View: | Wheeler Kurt 10% Owner | SenoRx, Inc. (SENO) | 25-Jun-10 | Market Sale Duplicate | 161,293 | $10.97 | $1,769,380.00 | (4%) 4.23M to 4.06M | < 1% |
| 29-Jun-10 2:01 PM View: | Mpm Bioventures II Qp Lp 10% Owner | SenoRx, Inc. (SENO) | 25-Jun-10 | Market Sale | 161,293 | $10.97 | $1,769,380.00 | (4%) 4.23M to 4.06M | < 1% |
| 28-Apr-10 3:40 PM View: | Mpm Bioventures II Qp Lp 10% Owner | SenoRx, Inc. (SENO) | 27-Apr-10 | Market Sale | 13,900 | $10.09 | $140,251.00 | (< 1%) 4.42M to 4.4M | 3% |
| 28-Apr-10 3:42 PM View: | Wheeler Kurt 10% Owner | SenoRx, Inc. (SENO) | 27-Apr-10 | Market Sale Duplicate | 13,900 | $10.09 | $140,251.00 | (< 1%) 4.42M to 4.4M | 3% |
| 28-Apr-10 3:42 PM View: | Wheeler Kurt 10% Owner | SenoRx, Inc. (SENO) | 26-Apr-10 | Market Sale Duplicate | 1,000 | $10.05 | $10,050.00 | (< 1%) 4.42M to 4.42M | 3% |
| 28-Apr-10 3:40 PM View: | Mpm Bioventures II Qp Lp 10% Owner | SenoRx, Inc. (SENO) | 26-Apr-10 | Market Sale | 1,000 | $10.05 | $10,050.00 | (< 1%) 4.42M to 4.42M | 3% |
| 26-Apr-10 5:31 PM View: | Wheeler Kurt 10% Owner | SenoRx, Inc. (SENO) | 23-Apr-10 | Market Sale | 1,900 | $10.07 | $19,133.00 | (< 1%) 4.42M to 4.42M | 2% |
| 26-Apr-10 5:31 PM View: | Mpm Bioventures II Qp Lp 10% Owner | SenoRx, Inc. (SENO) | 23-Apr-10 | Market Sale Duplicate | 1,900 | $10.07 | $19,133.00 | (< 1%) 4.42M to 4.42M | 2% |
| 26-Apr-10 5:31 PM View: | Mpm Bioventures II Qp Lp 10% Owner | SenoRx, Inc. (SENO) | 22-Apr-10 | Market Sale Duplicate | 31,811 | $10.06 | $320,019.00 | (< 1%) 4.45M to 4.42M | 2% |
| 26-Apr-10 5:31 PM View: | Wheeler Kurt 10% Owner | SenoRx, Inc. (SENO) | 22-Apr-10 | Market Sale | 31,811 | $10.06 | $320,019.00 | (< 1%) 4.45M to 4.42M | 2% |
| 07-Jul-10 7:47 PM View: | Blickenstaff Kim D Director | SenoRx, Inc. (SENO) | 26-Feb-10 | Option Exercise | 652 | -- | -- | 100% 0 to 0.65K | |
| 07-Jul-10 7:14 PM View: | Buhler John T CEO, President & COO Director | SenoRx, Inc. (SENO) | 26-Feb-10 | Option Exercise | 3,049 | -- | -- | 73% 4.2K to 7.25K | |
| 07-Jul-10 7:18 PM View: | Lubock Paul SVP & Chief Technology Officer | SenoRx, Inc. (SENO) | 26-Feb-10 | Option Exercise | 3,049 | -- | -- | 2% 192.62K to 195.67K | |
| 07-Jul-10 7:25 PM View: | Gearhart William F VP, Global Mkting & Corp. Dev. | SenoRx, Inc. (SENO) | 26-Feb-10 | Option Exercise | 1,913 | -- | -- | 6% 32.43K to 34.34K | |
| 07-Jul-10 7:49 PM View: | Capps Vickie L Director | SenoRx, Inc. (SENO) | 26-Feb-10 | Option Exercise | 652 | -- | -- | 4% 15.0K to 15.65K | |
| 07-Jul-10 7:51 PM View: | Dotzler Frederick J Director | SenoRx, Inc. (SENO) | 26-Feb-10 | Option Exercise | 652 | -- | -- | < 1% 739.51K to 740.17K | |
| 07-Jul-10 7:26 PM View: | Gordon Eben S VP, Regulatory Affairs | SenoRx, Inc. (SENO) | 26-Feb-10 | Payment of Exercise | 842 | $7.19 | $6,053.98 | (5%) 16.2K to 15.36K | (53%) |
| 07-Jul-10 7:17 PM View: | Cousins Kevin J VP, Finance and CFO | SenoRx, Inc. (SENO) | 26-Feb-10 | Payment of Exercise | 1,106 | $7.19 | $7,952.14 | (2%) 53.69K to 52.58K | (53%) |
| 07-Jul-10 7:28 PM View: | Bender A Thomas Director | SenoRx, Inc. (SENO) | 26-Feb-10 | Option Exercise | 652 | -- | -- | 2% 36.0K to 36.65K | |
| 07-Jul-10 7:53 PM View: | Waller Gregory D Director | SenoRx, Inc. (SENO) | 26-Feb-10 | Option Exercise | 652 | -- | -- | 100% 0 to 0.65K | |
| 07-Jul-10 7:14 PM View: | Buhler John T CEO, President & COO Director | SenoRx, Inc. (SENO) | 26-Feb-10 | Payment of Exercise | 1,119 | $7.19 | $8,045.61 | (15%) 7.25K to 6.13K | (53%) |
| 07-Jul-10 7:18 PM View: | Lubock Paul SVP & Chief Technology Officer | SenoRx, Inc. (SENO) | 26-Feb-10 | Payment of Exercise | 1,196 | $7.19 | $8,599.24 | (< 1%) 195.67K to 194.48K | (53%) |
| 07-Jul-10 7:25 PM View: | Gearhart William F VP, Global Mkting & Corp. Dev. | SenoRx, Inc. (SENO) | 26-Feb-10 | Payment of Exercise | 825 | $7.19 | $5,931.75 | (2%) 34.34K to 33.52K | (53%) |
| 07-Jul-10 7:26 PM View: | Gordon Eben S VP, Regulatory Affairs | SenoRx, Inc. (SENO) | 26-Feb-10 | Option Exercise | 1,913 | -- | -- | 13% 14.29K to 16.2K | |
| 07-Jul-10 7:17 PM View: | Cousins Kevin J VP, Finance and CFO | SenoRx, Inc. (SENO) | 26-Feb-10 | Option Exercise | 2,760 | -- | -- | 5% 50.93K to 53.69K | |
| 07-Jul-10 7:52 PM View: | Erb John L Director | SenoRx, Inc. (SENO) | 26-Feb-10 | Option Exercise | 652 | -- | -- | 7% 10.0K to 10.65K | |
| 19-Nov-09 4:38 PM View: | Gearhart William F VP, Global Market/Corp Develop | SenoRx, Inc. (SENO) | 18-Nov-09 | Option Exercise | 31,428 | $0.88 | $27,499.50 | 100% 0 to 31.43K | |
| 10-Nov-09 12:51 PM View: | Lubock Paul Sr VP and Chief Tech Officer | SenoRx, Inc. (SENO) | 06-Nov-09 | Gift | 67,489 | -- | -- | (26%) 258.14K to 190.65K | |
| 14-Aug-09 3:59 PM View: | Bender A Thomas Director | SenoRx, Inc. (SENO) | 12-Aug-09 | Market Purchase | 1,000 | $4.30 | $4,300.00 | 3% 35.0K to 36.0K | 2% |
| 13-Aug-09 1:30 PM View: | Bender A Thomas Director | SenoRx, Inc. (SENO) | 11-Aug-09 | Market Purchase | 2,000 | $4.20 | $8,400.00 | 6% 33.0K to 35.0K | 2% |
| 13-Aug-09 1:30 PM View: | Bender A Thomas Director | SenoRx, Inc. (SENO) | 10-Aug-09 | Market Purchase | 2,000 | $4.15 | $8,300.00 | 6% 31.0K to 33.0K | 4% |
| 10-Aug-09 1:11 PM View: | Bender A Thomas Director | SenoRx, Inc. (SENO) | 07-Aug-09 | Market Purchase | 4,000 | $4.03 | $16,120.20 | 15% 27.0K to 31.0K | < 1% |
| 26-May-09 8:47 PM View: | Bender A Thomas Director | SenoRx, Inc. (SENO) | 22-May-09 | Market Purchase | 2,000 | $3.38 | $6,760.00 | 8% 25.0K to 27.0K | (1%) |
| 21-May-09 7:57 PM View: | Bender A Thomas Director | SenoRx, Inc. (SENO) | 21-May-09 | Market Purchase | 2,000 | $3.39 | $6,780.00 | 9% 23.0K to 25.0K | < 1% |
| 21-May-09 7:57 PM View: | Bender A Thomas Director | SenoRx, Inc. (SENO) | 20-May-09 | Market Purchase | 2,000 | $3.29 | $6,573.00 | 10% 21.0K to 23.0K | 4% |
| 20-May-09 7:24 PM View: | Bender A Thomas Director | SenoRx, Inc. (SENO) | 19-May-09 | Market Purchase | 2,000 | $3.05 | $6,105.08 | 11% 19.0K to 21.0K | (< 1%) |
